Last updated on August 2016

Study of Motilitone to Treat Functional Dyspepsia

Brief description of study

This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.

Clinical Study Identifier: NCT02365701


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Madhusudan Grover, MBBS

Mayo Clinic
Rochester, MN United States
  Connect »